Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Looking for reliable websites to aid your investment learning? Check out our curated list of resources that support new investors on their journey.
28,161 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As silver prices drive market chatter in 2026, traders compare SIL and SILJ. The choice hinges on exposure to establi...
When a company’s chairman unloads a sizable stake, investors naturally want to know why. This article breaks down a r...
In a high-profile auction tied to Berkshire's annual meeting, a signed commemorative book changed hands for $50,000, ...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Trump’s fury spain working as Washington weighs new trade moves against Madrid, drawing a sharp response from Spain a...
Permanent Portfolio's Michael Cuggino argues Meta can invest heavily in AI without sacrificing profits. He emphasizes...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
Ford shows a weakness in its truck lineup, and GM may push harder to capture share in the high-margin segment. This a...
The spmc 2026 earnings call offers a clear view of growth, margins, and cash flow. This article breaks down the highl...
Broadcom posted a record AI-led quarter, while Qualcomm balanced handset softness with rising auto and licensing mome...